‼️The most read paper in 2025:

2024: The Year in #Cardiovascular #Disease - The Year of Lipoprotein(a) #LPA – Research Advances and New Findings.

@rblument1.bsky.social @alexrazavi.bsky.social

www.archivesofmedicalscience.com/2024-The-Yea...

Our new review on the evidence for primary prevention aspirin in individuals with elevated Lp(a) is out now. #CardioSky

@ucsdcardiology.bsky.social @aspcardio.bsky.social @familyheartfdn.bsky.social

link.springer.com/epdf/10.1007...

Allocation of #Semaglutide According to #CAC & BMI: Applying the SELECT Trial to MESA

#CardioSky #MedSky #JACCIMG
www.jacc.org/doi/10.1016/...
@jaccjournals.bsky.social @alexrazavi.bsky.social @michaeldshapiro.bsky.social @rblument1.bsky.social @hopkinsheart.bsky.social @erinmichos.bsky.social

Traditional Risk Factors, Optimal CV Health & Elevated Lipoprotein(a)

#CardioSky #MedSky #EJPC
@alexrazavi.bsky.social @hsbhatia.bsky.social
academic.oup.com/eurjpc/advan...

In our new study in EJPC, optimal CVD risk factor control was a/w lower risk across Lp(a) levels, though residual risk remains. These results show the importance of aggressive risk factor mgmt in patients with elevated Lp(a). @alexrazavi.bsky.social

academic.oup.com/eurjpc/advan...

Polygenic Risk Scores & Extreme #CAC Phenotypes in Adults ≥75 Years Old: ARIC Study

#Circulation #CardioSky #YesCCT
@pnatarajanmd.bsky.social @erinmichos.bsky.social @ahascience.bsky.social @ahajournals.bsky.social @alexrazavi.bsky.social
www.ahajournals.org/doi/10.1161/...